RNA-lipid nanoparticle complexes of viral RNA polymerase region and SARS-CoV-2 spike protein region
US11376335B2 · kind B2 · utility
9Cited by
11References
29Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 2021 |
| Grant date | Jul 5, 2022 |
| Priority date | — |
| Expiry date | Nov 10, 2041 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A50/30
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The disclosure provides nanoemulsion compositions and methods of making and using thereof to deliver a bioactive agent such as a nucleic acid to a subject. The nanoemulsion composition comprises a hydrophobic core based on inorganic nanoparticles in a lipid nanoparticle that allows imaging as well as delivering nucleic acids. Methods of using these particles for treatment and vaccination are also provided.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.